Connect Biopharma Holdings Limited (CNTB)
NASDAQ·Healthcare·Biotechnology
$2.13
+1.19%
Mkt Cap $148.14M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$6.33
Range $4.00 – $9.00
Implied Upside
+197.9%
Consensus $6.33 vs current $2.13